1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. IN8BIO INC
IN8bio Inc
XNAS: INAB
Download real time
1.49 -0.10 (-6.29%)
64.27% Fall from 52W High
130.8K
XNAS Volume
High volume+loss today

XNAS 15 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for IN8bio Inc

The latest disclosure was made by Peter C. Brandt in IN8bio Inc where a trade of 22,000 Stock Option (right to buy) done was reported to US exchanges on May 9, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Peter C. Brandt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2026 22,000 22,000 - - Stock Option (right to buy)
William Ho Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2026 154,500 154,500 - - Employee Stock Option (right to buy)
Lawrence Lamb EVP and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2026 54,000 54,000 - - Employee Stock Option (right to buy)
Emily Wang Fairbairn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2026 22,000 22,000 - - Stock Option (right to buy)
Luba Greenwood Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2026 22,000 22,000 - - Stock Option (right to buy)
Patrick McCall CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2026 56,250 56,250 - - Employee Stock Option (right to buy)
Kate Rochlin President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2026 60,000 60,000 - - Employee Stock Option (right to buy)
Jeremy R. Graff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2026 22,000 22,000 - - Stock Option (right to buy)
William Ho Director, CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2026 206,000 206,000 - - Employee Stock Option (right to buy)
Lawrence Lamb EVP and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2026 72,000 72,000 - - Employee Stock Option (right to buy)
Patrick McCall CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2026 75,000 75,000 - - Employee Stock Option (right to buy)
Kate Rochlin President and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2026 80,000 80,000 - - Employee Stock Option (right to buy)
Peter C. Brandt Director Grant, award, or other acquisition of securities at price $ 1.38 per share. 22 Dec 2025 72,464 95,181 - 1.4 100,000 Common Stock
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 1.38 per share. 22 Dec 2025 36,232 49,514 - 1.4 50,000 Common Stock
William Ho Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 1.38 per share. 22 Dec 2025 36,232 121,168 - 1.4 50,000 Common Stock
Emily Wang Fairbairn Director Grant, award, or other acquisition of securities at price $ 1.38 per share. 22 Dec 2025 724,637 724,637 - 1.4 999,999 Common Stock
Patrick McCall CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 1.38 per share. 22 Dec 2025 7,247 9,482 - 1.4 10,001 Common Stock
Kate Rochlin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 1.38 per share. 22 Dec 2025 7,247 9,085 - 1.4 10,001 Common Stock
Peter C. Brandt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2025 63,150 63,150 - - Stock Option (right to buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2025 63,150 63,150 - - Stock Option (right to buy)
Emily Wang Fairbairn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2025 63,150 63,150 - - Stock Option (right to buy)
Luba Greenwood Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2025 63,150 63,150 - - Stock Option (right to buy)
Jeremy R. Graff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2025 63,150 63,150 - - Stock Option (right to buy)
Peter C. Brandt Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Apr 2025 81,967 0 - - Series B Warrants (right to buy)
Peter C. Brandt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2025 81,967 81,967 - - Series B Warrants (right to buy)
Peter C. Brandt Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Apr 2025 81,967 0 - - Series B Warrants (right to buy)
Peter C. Brandt Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Apr 2025 81,967 0 - - Series A Warrants (right to buy)
Peter C. Brandt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2025 81,967 81,967 - - Series A Warrants (right to buy)
Peter C. Brandt Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Apr 2025 81,967 0 - - Series A Warrants (right to buy)
Peter C. Brandt Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.18 per share. 27 Apr 2025 81,967 599,571 - 0.2 15,115 Common Stock
Peter C. Brandt Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.18 per share. 27 Apr 2025 81,967 681,538 - 0.2 15,115 Common Stock
Alan S. Roemer Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.18 per share. 27 Apr 2025 102,459 387,489 - 0.2 18,893 Common Stock
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2025 91,459 91,459 - - Series B Warrants (right to buy)
Alan S. Roemer Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Apr 2025 11,000 0 - - Series B Warrants (right to buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2025 11,000 11,000 - - Series B Warrants (right to buy)
Alan S. Roemer Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Apr 2025 102,459 0 - - Series B Warrants (right to buy)
Alan S. Roemer Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Apr 2025 102,459 0 - - Series A Warrants (right to buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2025 102,459 102,459 - - Series A Warrants (right to buy)
Alan S. Roemer Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Apr 2025 102,459 0 - - Series A Warrants (right to buy)
Alan S. Roemer Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.18 per share. 27 Apr 2025 11,000 398,489 - 0.2 2,028 Common Stock
William Ho Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2025 81,967 81,967 - - Pre-Funded Warrant (right to buy)
William Ho Director, PRESIDENT AND CEO, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Apr 2025 81,967 0 - - Series B Warrants (right to buy)
William Ho Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2025 81,967 81,967 - - Series B Warrants (right to buy)
William Ho Director, PRESIDENT AND CEO, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Apr 2025 81,967 0 - - Series A Warrants (right to buy)
Lawrence Lamb EVP and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2025 1,639 1,639 - - Series B Warrants (right to buy)
Lawrence Lamb EVP and CSO Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Apr 2025 1,639 0 - - Series B Warrants (right to buy)
Patrick McCall CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.18 per share. 27 Apr 2025 15,000 67,071 - 0.2 2,766 Common Stock
Patrick McCall CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2025 15,000 15,000 - - Series A Warrants (right to buy)
Patrick McCall CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Apr 2025 15,000 5,492 - - Series A Warrants (right to buy)
Patrick McCall CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2025 20,492 20,492 - - Series B Warrants (right to buy)
Patrick McCall CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Apr 2025 20,492 0 - - Series B Warrants (right to buy)
Patrick McCall CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Apr 2025 15,000 0 - - Series A Warrants (right to buy)
Kate Rochlin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2025 12,295 12,295 - - Series A Warrants (right to buy)
Kate Rochlin Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Apr 2025 12,295 0 - - Series A Warrants (right to buy)
Kate Rochlin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.18 per share. 27 Apr 2025 12,295 55,169 - 0.2 2,267 Common Stock
Kate Rochlin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2025 12,295 12,295 - - Series B Warrants (right to buy)
Kate Rochlin Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Apr 2025 12,295 0 - - Series B Warrants (right to buy)
Kate Rochlin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Apr 2025 12,295 0 - - Series A Warrants (right to buy)
Jeremy R. Graff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2025 2,049 2,049 - - Series B Warrants (right to buy)
Jeremy R. Graff Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Apr 2025 2,049 0 - - Series B Warrants (right to buy)
William Ho Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 912,450 912,450 - - Employee Stock Option (right to buy)
Lawrence Lamb EVP and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 306,750 306,750 - - Employee Stock Option (right to buy)
Patrick McCall CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 343,000 343,000 - - Employee Stock Option (right to buy)
Kate Rochlin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 338,950 338,950 - - Employee Stock Option (right to buy)
Whitfill Travis Director 19 Dec 2024 42,676 42,676 - - Stock Option (right to buy)
S. Roemer Alan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 93,242 93,242 - - Stock Option (right to buy)
Patrick McCall CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 290,085 290,085 - - Employee Stock Option (right to buy)
Wang Emily Fairbairn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 31,559 31,559 - - Stock Option (right to buy)
Luba Greenwood Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 39,449 39,449 - - Stock Option (right to buy)
Rochlin Kate Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 302,839 302,839 - - Employee Stock Option (right to buy)
William Ho Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 1,188,282 1,188,282 - - Employee Stock Option (right to buy)
Jeremy Graff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 47,697 47,697 - - Stock Option (right to buy)
Brandt C. Peter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 49,490 49,490 - - Stock Option (right to buy)
Lawrence Lamb EVP and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2024 286,899 286,899 - - Employee Stock Option (right to buy)
Peter C. Brandt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2024 253,164 517,604 - - Common Stock
Peter C. Brandt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2024 253,164 253,164 - - Series C Warrants (right to buy)
Peter C. Brandt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2024 81,967 81,967 - - Series A Warrants (right to buy)
Peter C. Brandt Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Oct 2024 81,967 0 - - Series A Warrants (right to buy)
Alan S. Roemer Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Oct 2024 102,459 0 - - Series A Warrants (right to buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2024 126,582 126,582 - - Series C Warrants (right to buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2024 102,459 102,459 - - Series A Warrants (right to buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2024 126,582 285,030 - - Common Stock
William Ho Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2024 81,967 81,967 - - Series A Warrants (right to buy)
William Ho Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2024 126,582 2,548,094 - - Common Stock
William Ho Director, PRESIDENT AND CEO, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Oct 2024 81,967 0 - - Series A Warrants (right to buy)
William Ho Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2024 126,582 126,582 - - Series C Warrants (right to buy)
Emily Wang Fairbairn Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Oct 2024 3,038,743 3,038,743 - - Pre-Funded Warrants (right to buy)
Emily Wang Fairbairn Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Oct 2024 3,038,743 3,038,743 - - Series C Warrants (right to buy)
Patrick McCall CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2024 25,316 25,316 - - Series C Warrants (right to buy)
Patrick McCall CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2024 20,492 20,492 - - Series A Warrants (right to buy)
Patrick McCall CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Oct 2024 20,492 0 - - Series A Warrants (right to buy)
Patrick McCall CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2024 25,316 52,071 - - Common Stock
Kate Rochlin Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Oct 2024 12,295 0 - - Series A Warrants (right to buy)
Kate Rochlin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2024 25,316 25,316 - - Series C Warrants (right to buy)
Kate Rochlin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2024 25,316 42,874 - - Common Stock
Kate Rochlin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2024 12,295 12,295 - - Series A Warrants (right to buy)
William Ho Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Sep 2024 500,000 500,000 - - Employee Stock Option (right to buy)
Lawrence Lamb EVP and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Sep 2024 250,000 250,000 - - Employee Stock Option (right to buy)
Patrick McCall CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Sep 2024 250,000 250,000 - - Employee Stock Option (right to buy)
Trishna Goswami Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Sep 2024 250,000 250,000 - - Employee Stock Option (right to buy)
Kate Rochlin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Sep 2024 250,000 250,000 - - Employee Stock Option (right to buy)
Peter C. Brandt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 33,650 33,650 - - Stock Option (right to buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 33,650 33,650 - - Stock Option (right to buy)
Travis Whitfill Director 12 Jun 2024 33,650 33,650 - - Stock Option (right to buy)
Emily Wang Fairbairn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 33,650 33,650 - - Stock Option (right to buy)
Luba Greenwood Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 33,650 33,650 - - Stock Option (right to buy)
Jeremy Graff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 33,650 33,650 - - Stock Option (right to buy)
Trishna Goswami CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 176,000 176,000 - - Employee Stock Option (right to buy)
Lawrence Lamb EVP AND CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 169,000 169,000 - - Employee Stock Option (right to buy)
McCall Patrick CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 189,000 189,000 - - Employee Stock Option (right to buy)
Ho William Director, PRESIDENT AND CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 502,000 502,000 - - Employee Stock Option (right to buy)
Kate Rochlin CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 186,000 186,000 - - Employee Stock Option (right to buy)
McCall Patrick Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 20,492 20,492 - - Series A Warrants (right to buy)
Lamb Lawrence EVP and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 1,639 1,639 - - Series B Warrants (right to buy)
Alan Roemer S. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 102,459 102,459 - - Series A Warrants (right to buy)
Rochlin Kate Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 12,295 12,295 - - Series B Warrants (right to buy)
Brandt Peter C. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 81,967 81,967 - - Series A Warrants (right to buy)
C. Brandt Peter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 81,967 264,440 - - Common Stock
C. Peter Brandt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 81,967 81,967 - - Series B Warrants (right to buy)
William Ho Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 81,967 2,421,512 - - Common Stock
Ho William Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 81,967 81,967 - - Series B Warrants (right to buy)
Trishna Goswami Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 4,098 4,098 - - Series A Warrants (right to buy)
Kate Rochlin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 12,295 12,295 - - Series A Warrants (right to buy)
Jeremy Graff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 2,049 4,549 - - Common Stock
Graff Jeremy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 2,049 2,049 - - Series A Warrants (right to buy)
Lawrence Lamb EVP and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 1,639 1,639 - - Series A Warrants (right to buy)
Goswami Trishna Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 4,098 4,098 - - Series B Warrants (right to buy)
Goswami Trishna Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 4,098 6,729 - - Common Stock
Patrick McCall Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 20,492 20,492 - - Series B Warrants (right to buy)
Graff Jeremy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 2,049 2,049 - - Series B Warrants (right to buy)
Rochlin Kate Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 12,295 17,558 - - Common Stock
William Ho Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 81,967 81,967 - - Series A Warrants (right to buy)
Lamb Lawrence EVP and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 1,639 101,369 - - Common Stock
Roemer Alan S. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 102,459 158,448 - - Common Stock
S. Roemer Alan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 102,459 102,459 - - Series B Warrants (right to buy)
McCall Patrick Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 20,492 26,755 - - Common Stock
Patrick McCall Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.03 per share. 25 Aug 2023 1,000 6,263 - 1.0 1,030 Common Stock
William Ho Director, President and CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.05 per share. 24 Aug 2023 23,800 2,339,545 - 1.1 24,990 Common Stock
Emily Wang Fairbairn Director Other type of transaction at price $ 0.00 per share. 28 Jul 2023 4,111,958 0 - 0 Common Stock
William Ho Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2023 393,950 393,950 - - Employee Stock Option (right to buy)
Lawrence Lamb EVP and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2023 77,600 77,600 - - Employee Stock Option (right to buy)
Patrick McCall Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2023 87,150 87,150 - - Employee Stock Option (right to buy)
Trishna Goswami Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2023 134,000 134,000 - - Employee Stock Option (right to buy)
Kate Rochlin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2023 67,800 67,800 - - Employee Stock Option (right to buy)
Jeremy Graff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2023 27,000 27,000 - - Stock Option (right to buy)
William Ho Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2023 393,950 393,950 - - Employee Stock Option (right to buy)
Lawrence Lamb EVP and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2023 200,000 200,000 - - Employee Stock Option (right to buy)
Patrick McCall Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2023 200,000 200,000 - - Employee Stock Option (right to buy)
Trishna Goswami Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2023 200,000 200,000 - - Employee Stock Option (right to buy)
Kate Rochlin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2023 200,000 200,000 - - Employee Stock Option (right to buy)
William Ho Director, President, CEO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2022 83,265 83,265 - - Employee Stock Option (right to buy)
Lawrence Lamb EVP and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2022 62,826 62,826 - - Employee Stock Option (right to buy)
Patrick McCall Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2022 59,796 59,796 - - Employee Stock Option (right to buy)
Trishna Goswami Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2022 68,427 68,427 - - Employee Stock Option (right to buy)
Kate Rochlin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2022 60,555 60,555 - - Employee Stock Option (right to buy)
Peter C. Brandt Director Purchase of securities on an exchange or from another person at price $ 1.90 per share. 16 Aug 2022 105,263 182,473 - 1.9 200,000 Common Stock
Alan S. Roemer Director Purchase of securities on an exchange or from another person at price $ 1.90 per share. 16 Aug 2022 26,315 55,989 - 1.9 49,999 Common Stock
William Ho Director, President, CEO and CFO Purchase of securities on an exchange or from another person at price $ 1.90 per share. 16 Aug 2022 26,315 2,315,745 - 1.9 49,999 Common Stock
Lawrence Lamb EVP and CSO Purchase of securities on an exchange or from another person at price $ 1.90 per share. 16 Aug 2022 526 99,730 - 1.9 999 Common Stock
Emily Wang Fairbairn Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.90 per share. 16 Aug 2022 789,473 4,111,958 - 1.9 1,499,999 Common Stock
Luba Greenwood Director Purchase of securities on an exchange or from another person at price $ 1.90 per share. 16 Aug 2022 526 7,826 - 1.9 999 Common Stock
Patrick McCall Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.90 per share. 16 Aug 2022 5,263 5,263 - 1.9 10,000 Common Stock
Trishna Goswami Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 1.90 per share. 16 Aug 2022 2,631 2,631 - 1.9 4,999 Common Stock
Kate Rochlin Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 1.90 per share. 16 Aug 2022 5,263 5,263 - 1.9 10,000 Common Stock
Peter C. Brandt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 13,500 13,500 - - Stock Option (right to buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 13,500 13,500 - - Stock Option (right to buy)
Travis Whitfill Director 01 Jun 2022 13,500 13,500 - - Stock Option (right to buy)
Emily Wang Fairbairn Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 13,500 13,500 - - Stock Option (right to buy)
Luba Greenwood Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 13,500 13,500 - - Stock Option (right to buy)
Lawrence Lamb EVP and CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share. 05 May 2022 26,204 99,204 - 1.1 27,999 Common Stock
Lawrence Lamb EVP and CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 May 2022 26,204 1,171 - - Employee Stock Option (right to buy)
William Ho Director, President, CEO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 254,500 254,500 - - Employee Stock Option (right to buy)
Lawrence Lamb EVP and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 62,500 62,500 - - Employee Stock Option (right to buy)
Patrick McCall Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 84,500 84,500 - - Employee Stock Option (right to buy)
Trishna Goswami Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 90,500 90,500 - - Employee Stock Option (right to buy)
Kate Rochlin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 96,000 96,000 - - Employee Stock Option (right to buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Nov 2021 86,258 86,258 - - Stock Option (right to buy)
Trishna Goswami Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Nov 2021 250,000 250,000 - - Employee Stock Option (right to buy)
William Ho Director, President, CEO and CFO 03 Aug 2021 3,070 72,999 - - Common Stock
William Ho Director, President, CEO and CFO 03 Aug 2021 2,792 0 - - Series A Preferred Stock
Lawrence Lamb EVP and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2021 22,082 83,582 - - Employee Stock Option (right to buy)
Peter C. Brandt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2021 10,500 10,500 - - Stock Option (right to buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2021 10,500 10,500 - - Stock Option (right to buy)
William Ho Director, President, CEO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2021 220,500 220,500 - - Employee Stock Option (right to buy)
Lawrence Lamb EVP and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2021 61,500 61,500 - - Employee Stock Option (right to buy)
Travis Whitfill Director 29 Jul 2021 10,500 10,500 - - Stock Option (right to buy)
Patrick McCall Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2021 40,000 40,000 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters